↓ Skip to main content

Therapeutic applications of circadian rhythms for the cardiovascular system

Overview of attention for article published in Frontiers in Pharmacology, April 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
92 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Therapeutic applications of circadian rhythms for the cardiovascular system
Published in
Frontiers in Pharmacology, April 2015
DOI 10.3389/fphar.2015.00077
Pubmed ID
Authors

Elena V Tsimakouridze, Faisal J Alibhai, Tami A Martino

Abstract

The cardiovascular system exhibits dramatic time-of-day dependent rhythms, for example the diurnal variation of heart rate, blood pressure, and timing of onset of adverse cardiovascular events such as heart attack and sudden cardiac death. Over the past decade, the circadian clock mechanism has emerged as a crucial factor regulating these daily fluctuations. Most recently, these studies have led to a growing clinical appreciation that targeting circadian biology offers a novel therapeutic approach toward cardiovascular (and other) diseases. Here we describe leading-edge therapeutic applications of circadian biology including (1) timing of therapy to maximize efficacy in treating heart disease (chronotherapy); (2) novel biomarkers discovered by testing for genomic, proteomic, metabolomic, or other factors at different times of day and night (chronobiomarkers); and (3) novel pharmacologic compounds that target the circadian mechanism with potential clinical applications (new chronobiology drugs). Cardiovascular disease remains a leading cause of death worldwide and new approaches in the management and treatment of heart disease are clearly warranted and can benefit patients clinically.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 92 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 23%
Researcher 12 13%
Student > Bachelor 11 12%
Student > Ph. D. Student 11 12%
Other 10 11%
Other 12 13%
Unknown 15 16%
Readers by discipline Count As %
Medicine and Dentistry 23 25%
Agricultural and Biological Sciences 14 15%
Biochemistry, Genetics and Molecular Biology 10 11%
Pharmacology, Toxicology and Pharmaceutical Science 7 8%
Neuroscience 6 7%
Other 12 13%
Unknown 20 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 January 2021.
All research outputs
#7,123,792
of 22,799,071 outputs
Outputs from Frontiers in Pharmacology
#2,937
of 16,017 outputs
Outputs of similar age
#85,424
of 264,854 outputs
Outputs of similar age from Frontiers in Pharmacology
#20
of 80 outputs
Altmetric has tracked 22,799,071 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 16,017 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 264,854 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.